UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that ...
Hosted on MSN
Why Is ProPhase Labs Stock (PRPH) Up 25% Today?
ProPhase Labs (PRPH) stock took off on Tuesday after the consumer healthcare company announced a patent update. The U.S. Patent and Trademark Office has issued its approval for a patent that covers ...
GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today reported its ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
In a challenging year for ProPhase Labs, now valued at just $10 million in market cap, the company's stock has plummeted to a 52-week low, touching down at $0.41. This significant downturn reflects a ...
UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today ...
Navidea Biopharmaceuticals Inc. NAVB announced Friday that it had rejected an unsolicited ProPhase Labs Inc. PRPH offer for certain Navidea assets, saying the proposal undervalues Navidea and is not ...
UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today ...
Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced positive preliminary results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback